MedTrace Logo

Virtual Reality and Technologies for Elderly

NCT06076148 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2025-07-29

Study results available
· View outcomes & findings →

Summary

The objective of this clinical trial is to understand the determinants and opportunities for acceptance of immersive technologies to support physical, cognitive, and social health and the possibilities for "aging well" among the new generation of older adults. The main questions it aims to answer are:

* What are the needs and expectations in terms of immersive activities and intervention methods according to age?
* Do different game modes influence the needs and expectations in immersive activities of this population? 50 participants will be asked to complete a preliminary questionnaire about their activity habits and preferences. They will then be invited to participate in individual or multiplayer virtual reality game trials, a post-trial discussion about their experience and a questionnaire completion.

Conditions

  • Aging Well

Interventions

DEVICE

Virtual reality games

three individual games (physical, cognitive and relaxation) and two multiplayer games will be tested.

Sponsors & Collaborators

  • Natural Sciences and Engineering Research Council, Canada

    collaborator OTHER

  • SEC Fonds Immobilier Groupe Maurice

    collaborator UNKNOWN

  • Fédération Québécoise des Loisirs en Institution

    collaborator UNKNOWN

  • Fédération de l'Age D'Or du Québec

    collaborator UNKNOWN

  • TOPMED

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-14
Primary Completion
2024-02-09
Completion
2024-02-09

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06076148 on ClinicalTrials.gov